Emirates SkyCargo, the global leader in the air transport of temperature sensitive pharmaceuticals, is marking an important operational milestone.
Five years ago, in September 2016, Emirates SkyCargo began transport of pharmaceuticals by launching its dedicated GDP certified pharma handling facility at Dubai International Airport and at the same time unveiling its three-tiered specialised product – Emirates Pharma.
Nabil Sultan, Emirates Divisional Senior Vice President, Cargo, said: “At Emirates SkyCargo, we recognised very early on that our customers were looking for increasingly specialised solutions for their cargo and this was true especially for valuable and life-saving medicines that have to be transported under very strict conditions.
“After extensive planning and significant investment to our infrastructure, processes and people, we introduced our 360 degree transportation solution backed by state of the art GDP certified Dubai handling facility for our pharma customers in September 2016.
“The response from the market was overwhelmingly positive and we managed to very quickly transform the perception that Dubai was a destination to be avoided for pharma cargo in the summer to that of Dubai being a reliable hub for pharma customers all year round.
“Our pharma volumes have continued to grow over the years and to date we have transported more than 400 million kilos (400, 000 tonnes) of pharma cargo under our Emirates Pharma umbrella.”
Hub Dubai: Emirates SkyCargo has over 20,000 sq. metres of GDP compliant storage and handling space at its hub in Dubai processing close to 200,000 kilos (200 tonnes) of pharmaceuticals every single day comprising vaccines, biologics, medicines for illnesses such as cancer, diabetes and a range of other medical treatments.
Emirates SkyCargo’s pharma operations in Dubai have undergone rigorous evaluation for compliance to GDP guidelines by Bureau Veritas, Germany including two full certification cycles involving multiple certification and surveillance audits.
Emirates SkyCargo’s pharma operations have also successfully undergone multiple audits conducted by customers and pharmaceutical manufacturers.